PDS Biotechnology Corp (PDSB)
3.62
+0.27
(+8.06%)
USD |
NASDAQ |
May 01, 16:00
3.62
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Cash from Operations (TTM): -33.64M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.64M |
| September 30, 2023 | -32.71M |
| June 30, 2023 | -31.42M |
| March 31, 2023 | -32.53M |
| December 31, 2022 | -25.71M |
| September 30, 2022 | -22.68M |
| June 30, 2022 | -21.92M |
| March 31, 2022 | -15.05M |
| December 31, 2021 | -12.49M |
| September 30, 2021 | -12.61M |
| June 30, 2021 | -8.737M |
| March 31, 2021 | -13.79M |
| December 31, 2020 | -13.15M |
| September 30, 2020 | -14.04M |
| June 30, 2020 | -17.12M |
| March 31, 2020 | -17.87M |
| December 31, 2019 | -18.07M |
| Date | Value |
|---|---|
| September 30, 2019 | -44.45M |
| June 30, 2019 | -40.56M |
| March 31, 2019 | -36.12M |
| December 31, 2018 | -33.15M |
| September 30, 2018 | -10.49M |
| June 30, 2018 | -21.46M |
| March 31, 2018 | -30.33M |
| December 31, 2017 | -40.70M |
| September 30, 2017 | -37.50M |
| June 30, 2017 | -34.90M |
| March 31, 2017 | -33.89M |
| December 31, 2016 | -32.19M |
| September 30, 2016 | -32.93M |
| June 30, 2016 | -29.13M |
| March 31, 2016 | -26.56M |
| December 31, 2015 | -21.75M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-44.45M
Minimum
Sep 2019
-8.737M
Maximum
Jun 2021
-22.56M
Average
-18.07M
Median
Dec 2019
Cash from Operations (TTM) Benchmarks
| Syros Pharmaceuticals Inc | -109.71M |
| PAVmed Inc | -52.04M |
| Altimmune Inc | -75.81M |
| Regeneron Pharmaceuticals Inc | 4.594B |
| iBio Inc | -18.89M |